Document is current

Article History

Received: 25 December 2024

Accepted: 9 April 2025

First Online: 30 April 2025

Declarations

:

: This clinical study was conducted in accordance with the ethical principles contained within Declaration of Helsinki, Protection of Human Volunteers (21 CFR 50), and Obligations of Clinical Investigators (21 CFR 812). The study was completed using retrospective data analysis on deidentified data, therefore IRB approval was not sought. The U.S. Department of Health and Human Services (HHS) regulations under 45 CFR 46.101(b), research involving the collection or study of existing data, documents, records, or specimens can be exempt from IRB review if these sources if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects. This is outlined in 45 CFR 46.104(d)(4) of the revised Common Rule.

: N/A.

: Only Author Sean McCafferty has a competing interest: The Submitted manuscript titled"Intraocular Pressure Correlation to Progressive Retinal Nerve Fiber Layer Loss in Primary Open Angle Glaucoma as measured by Standard and Modified Goldmann Applanation Tonometers"was completed by referencing studies with funding from an NIH/NEI SBIR grant 1R43 EY026821 - 01. Requirements of this grant are commercialization of potentially beneficial ophthalmic/optometric medical devices/products. The commercialization necessitates intellectual property and a company to produce the product. Commonly in new technology start-up companies (and in this case), an author is also part owner in the intellectual property and the associated company (Intuor Technologies). This is a conflict of interest. However, the authors attest to the stringent efforts made to provide unbiased information provided in this manuscript.